< Back to latest news & events

UPC

Agreement reached on the distribution of renewal fees in respect of Unitary Patents

November 2015

Agreement has been reached on the distribution of income that will be generated from renewal fees in respect of Unitary Patents. The EPO will be entitled to 50% of each renewal fee, while the other 50% will be distributed among the EU Member States participating in the Unitary Patent scheme, announced the EPO.

Within the announcement, the EPO President stated we could expect to see Unitary Patents as soon as mid 2016: “For its own part, the EPO is ready to implement the system. Provided that the EU Member States manage to ratify the Agreement establishing the Unified Patent Court in time, the first Unitary Patents could already be delivered in the second half of 2016”.

A separate announcement for the European Commission explained further that “50% of fees will be retained by the EPO while the remainder (minus an administrative charge) will be distributed among the participating countries according to a formula that takes account of the GDP and the number of applications filed from that country. The distribution arrangements will be reviewed regularly. The EPO will report on revenues and the fee distribution, and it will be possible, though not obligatory, to adapt the distribution key if practice differs greatly from projected figures. The distribution key will be subject to revision every five years.”

The Unitary Patent renewal fees have been already set a level roughly equivalent to what an applicant would normally pay for the four major countries under the classical European patent system. Since Italy acceded to the Unitary Patent Package on 30 September, this fee level has become more attractive.

Latest updates

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article